SEC Form 4 · accession 0001645627-15-000003
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Aug 19, 2015
Accepted (ET)
Aug 25, 2015 · 10:11 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 19, 2015 | P | 100 | $0.12 | A | 19,591,015 | D | |
| Michael Scott Mann | Aug 19, 2015 | P | 100 | $0.12 | A | 19,591,115 | D | |
| Michael Scott Mann | Aug 20, 2015 | P | 100 | $0.14 | A | 19,591,215 | D | |
| Common Stock | Aug 20, 2015 | P | 100 | $0.14 | A | 19,591,315 | D | |
| Michael Scott Mann | Aug 20, 2015 | P | 100 | $0.12 | A | 19,591,415 | D | |
| Michael Scott Mann | Aug 20, 2015 | P | 100 | $0.12 | A | 19,591,515 | D | |
| Michael Scott Mann | Aug 20, 2015 | P | 100 | $0.12 | A | 19,591,615 | D | |
| Michael Scott Mann | Aug 20, 2015 | P | 100 | $0.1189 | A | 19,591,715 | D | |
| Michael Scott Mann | Aug 20, 2015 | P | 100 | $0.119 | A | 19,591,815 | D | |
| Michael Scott Mann | Aug 21, 2015 | P | 100 | $0.1189 | A | 19,591,915 | D | |
| Michael Scott Mann | Aug 21, 2015 | P | 100 | $0.119 | A | 19,592,015 | D | |
| Michael Scott Mann | Aug 21, 2015 | P | 100 | $0.11 | A | 19,592,115 | D | |
| Michael Scott Mann | Aug 21, 2015 | P | 100 | $0.10 | A | 19,592,215 | D | |
| Michael Scott Mann | Aug 21, 2015 | P | 100 | $0.10 | A | 19,592,315 | D | |
| Michael Scott Mann | Aug 21, 2015 | P | 100 | $0.10 | A | 19,592,415 | D |
Table II — derivative securities
No Table II lines on this filing.